Sign In
Buy SDGR
$14.93
-0.0100 (-0.0669%)
At Close: Jun 03, 2026
Recursion Pharmaceuticals vs. Schrödinger: Which Healthcare Stock Is a Better Buy in 2026?
05:12pm, Tuesday, 02'nd Jun 2026
Two AI-driven disruptors, one biotech-focused, one software-first, post double-digit growth but diverge sharply on risk, cash flow, and valuation.
A Look at Schrodinger Inc (SDGR) After 6.9% Gain -- GF Value $26.55 vs Price $14.15
09:15pm, Thursday, 28'th May 2026
On May 28, 2026, Schrodinger Inc (SDGR) shares rose 6.9% to a current price of $14.15. The stock has experienced considerable volatility, with a 52-week range b
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
08:30am, Friday, 22'nd May 2026
NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR) today reported that on May 18, 2026, the company granted (i) a non-statutory stock option to purchase 1,875 shares of the company's common
My Top 3 Biotech Stocks for May 2026
11:15am, Wednesday, 20'th May 2026
As FDA activity accelerates and big pharma searches for its next generation of blockbuster drugs, select biotech companies are beginning to stand out from the crowd.
7 Healthcare AI Stocks Under $50 With Huge Upside Potential
07:35am, Monday, 18'th May 2026
Healthcare AI stocks have been hammered in 2026, with several names down 30% to 65% year to date even as their underlying platforms keep maturing.
Schrödinger, Inc. (SDGR) Presents at Bank of America Global Healthcare Conference 2026 Transcript
11:50pm, Wednesday, 13'th May 2026
Schrödinger, Inc. (SDGR) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Schrödinger, Inc. (SDGR) Q1 2026 Earnings Call Transcript
08:21pm, Tuesday, 05'th May 2026
Schrödinger, Inc. (SDGR) Q1 2026 Earnings Call Transcript
Schrodinger, Inc. (SDGR) Reports Q1 Loss, Misses Revenue Estimates
07:10pm, Tuesday, 05'th May 2026
Schrodinger, Inc. (SDGR) came out with a quarterly loss of $0.81 per share versus the Zacks Consensus Estimate of a loss of $0.56. This compares to a loss of $0.82 per share a year ago.
Schrödinger Reports First Quarter 2026 Financial Results
04:05pm, Tuesday, 05'th May 2026
NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. announced financial results for the quarter ended March 31, 2026.
Schrödinger to Participate in Upcoming Investor Conferences
08:30am, Monday, 04'th May 2026
NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR) today announced that management will participate in the following conferences in May: BofA Securities 2026 Healthcare Conference: Fireside
Schrodinger Inc (SDGR) Shares Fall 4.1% -- What GF Score of 69 Tells Investors
06:06pm, Wednesday, 22'nd Apr 2026
On April 22, 2026, Schrodinger Inc (SDGR) shares fell 4.1% today, bringing the current price to $12.35. The stock has experienced a 52-week range between $10.95
Schrödinger to Announce First Quarter 2026 Financial Results on May 5
08:30am, Tuesday, 21'st Apr 2026
NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR) will report its first quarter 2026 financial results on Tuesday, May 5, 2026, after the financial markets close. The company will host a co
Ramy Farid Sells 43,000 Shares of Schrodinger (NASDAQ:SDGR) Stock
04:36am, Sunday, 19'th Apr 2026
Schrodinger, Inc. (NASDAQ: SDGR - Get Free Report) CEO Ramy Farid sold 43,000 shares of the company's stock in a transaction on Thursday, April 16th. The shares were sold at an average price of $12.33
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
08:30am, Friday, 17'th Apr 2026
NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR) today reported that on April 16, 2026, the company granted restricted stock units (RSUs) with respect to 4,253 shares of the company's comm
Schrodinger, Inc. (NASDAQ:SDGR) Given Average Recommendation of “Hold” by Brokerages
03:00am, Saturday, 28'th Mar 2026
Schrodinger, Inc. (NASDAQ: SDGR - Get Free Report) has been given an average recommendation of "Hold" by the nine ratings firms that are presently covering the firm, MarketBeat reports. One research a
